NCT06383884 2025-12-15
Patritumab Deruxtecan in Patients With Solid Tumor Harboring an NRG1 Fusion
Samsung Medical Center
Phase 2 Recruiting
Clinical Trials
5 trialsNCT06032845 2025-02-27
CASTLE-11
Fudan University
Phase 2 Recruiting
NCT06003621 2024-11-15
MoST-TAP
Omico
Phase 2 Recruiting
NCT03274661 2023-10-19
Pembrolizumab Activity in Patients With Homologous Recombination Competent and Deficient Tumors
Baptist Health South Florida
Phase 2 Completed
NCT03017521 2021-04-22
K-BASKET, TAS-117, PI3K/AKT Gene Aberration
Yonsei University
Phase 2 Completed